NDC 36987-2073

Rhizopus oryzae

Rhizopus Oryzae

Rhizopus oryzae is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Rhizopus Arrhizus Var. Arrhizus.

Product ID36987-2073_42de87a6-4ad2-4dd1-ae19-915aec27f42c
NDC36987-2073
Product TypeHuman Prescription Drug
Proprietary NameRhizopus oryzae
Generic NameRhizopus Oryzae
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL; SUBCUTANEOUS
Marketing Start Date1972-08-29
Marketing CategoryBLA / BLA
Application NumberBLA102192
Labeler NameNelco Laboratories, Inc.
Substance NameRHIZOPUS ARRHIZUS VAR. ARRHIZUS
Active Ingredient Strength10000 [PNU]/mL
Pharm ClassesNon-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 36987-2073-1

5 mL in 1 VIAL, MULTI-DOSE (36987-2073-1)
Marketing Start Date1972-08-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 36987-2073-4 [36987207304]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-2073-2 [36987207302]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-2073-1 [36987207301]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-2073-3 [36987207303]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
RHIZOPUS ARRHIZUS VAR. ARRHIZUS10000 [PNU]/mL

OpenFDA Data

SPL SET ID:182f7346-1f19-44b1-bc8f-d7c543a1c4dc
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 999447
  • 967872
  • 967951
  • 999453
  • 999418
  • 967541
  • 999387
  • 889618
  • 307937
  • 999430
  • 999490
  • 867153
  • 999511
  • 999466
  • 968452
  • 968146
  • 1006333
  • 967041
  • 999460
  • 966952
  • 999400
  • 867175
  • 999441
  • 889540
  • 968482
  • 905077
  • 968350
  • 999501
  • 966687
  • 889585
  • 902638
  • 867181
  • 967055
  • Pharm Class PE
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Increased Histamine Release [PE]
  • PHarm Class EPC
  • Non-Standardized Fungal Allergenic Extract [EPC]
  • NUI Code
  • N0000185001
  • N0000175629
  • N0000171131
  • N0000185372
  • N0000169106
  • N0000184306
  • Pharmacological Class

    • Non-Standardized Fungal Allergenic Extract [EPC]
    • Increased Histamine Release [PE]
    • Cell-mediated Immunity [PE]
    • Increased IgG Production [PE]
    • Fungal Proteins [Chemical/Ingredient]
    • Allergens [Chemical/Ingredient]

    NDC Crossover Matching brand name "Rhizopus oryzae" or generic name "Rhizopus Oryzae"

    NDCBrand NameGeneric Name
    22840-2619Rhizopus oryzaeRhizopus oryzae
    22840-2620Rhizopus oryzaeRhizopus oryzae
    22840-2621Rhizopus oryzaeRhizopus oryzae
    22840-5633Rhizopus oryzaeRhizopus oryzae
    36987-2073Rhizopus oryzaeRhizopus oryzae
    36987-2074Rhizopus oryzaeRhizopus oryzae
    36987-2075Rhizopus oryzaeRhizopus oryzae
    36987-2076Rhizopus oryzaeRhizopus oryzae
    36987-2077Rhizopus oryzaeRhizopus oryzae
    36987-2078Rhizopus oryzaeRhizopus oryzae
    36987-2079Rhizopus oryzaeRhizopus oryzae
    36987-2080Rhizopus oryzaeRhizopus oryzae
    36987-2081Rhizopus oryzaeRhizopus oryzae
    49643-118RhizopusRhizopus oryzae

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.